Procoagulant Activity as a Marker in Prostate Cancer
Author Information
Author(s): A.S. Adamson, P. Luckert, M. Pollard, M.E. Snell, M. Amirkhosravi, J.L. Francis
Hypothesis
Does procoagulant activity reflect the malignant phenotype in prostate cancer?
Conclusion
Procoagulant activity is significantly higher in malignant prostate tissues and correlates with tumor aggressiveness.
Supporting Evidence
- PCA was significantly higher in rats with tumors compared to control groups.
- There was a positive correlation between tumor weight and PCA.
- PCA levels were higher in metastatic tumors than in localized tumors.
Takeaway
This study found that a certain activity in the blood related to clotting is higher in rats with prostate cancer, which might help doctors understand how aggressive the cancer is.
Methodology
The study used a one-stage kinetic chromogenic assay to measure procoagulant activity in rat prostate tissues.
Limitations
The study was conducted in rats, and caution is needed when extrapolating results to humans.
Participant Demographics
Lobund-Wistar rats, 3 months old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website